These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2501124)

  • 21. Regulation of prolactin secretion by dopamine and thyrotropin-releasing hormone in lactating rat adenohypophyses: influence of intracellular age of the hormone.
    Mena F; Clapp C; Aguayo D; Morales MT; Grosvenor CE; Martínez de la Escalera G
    Endocrinology; 1989 Oct; 125(4):1814-20. PubMed ID: 2507284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phorbol ester pretreatment attenuates the growth hormone (GH) response to GH-releasing factor in cultured rat pituitary cells.
    Ohmura E; Okada M; Ohba Y; Onoda N; Sano T; Tsushima T; Shizume K
    J Endocrinol; 1988 Sep; 118(3):423-8. PubMed ID: 3141549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of 45Ca2+ mobilization with stimulation of growth hormone (GH) release by GH-releasing factor in dispersed normal male rat pituitary cells.
    Login IS; Judd AM; MacLeod RM
    Endocrinology; 1986 Jan; 118(1):239-43. PubMed ID: 2866951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth hormone release: interaction of increased extracellular calcium and somatostatin.
    Stachura ME
    Endocr Res; 1986; 12(1):69-92. PubMed ID: 2870919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasoactive intestinal polypeptide and thyrotropin-releasing hormone stimulate newly synthesized, not stored, prolactin.
    Maas DL; Arnaout MA; Martinson DR; Erdmann MD; Hagen TC
    Endocrinology; 1991 Feb; 128(2):1015-20. PubMed ID: 1899215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of growth hormone-releasing factor, somatostatin and dopamine on growth hormone and prolactin secretion from cultured ovine pituitary cells.
    Law GJ; Ray KP; Wallis M
    FEBS Lett; 1984 Jan; 166(1):189-93. PubMed ID: 6141070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 12-O-tetradecanoyl phorbol-13-acetate stimulates rat growth hormone (GH) release through different pathways from that of human pancreatic GH-releasing factor.
    Ohmura E; Friesen HG
    Endocrinology; 1985 Feb; 116(2):728-33. PubMed ID: 2981678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular mechanism of caprylic acid-induced growth hormone suppression.
    Renier G; Abribat T; Brazeau P; Deslauriers N; Gaudreau P
    Metabolism; 1990 Oct; 39(10):1108-12. PubMed ID: 2170821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Actions of growth hormone-releasing factor and somatostatin on adenylate cyclase and growth hormone release in rat anterior pituitary.
    Harwood JP; Grewe C; Aguilera G
    Mol Cell Endocrinol; 1984 Oct; 37(3):277-84. PubMed ID: 6149968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-vitro control of growth hormone secretion by synthetic releasing factors in young and adult ducks (Anas platyrhynchos).
    Foltzer-Jourdainne C; Harvey S; Mialhe P
    J Endocrinol; 1988 Dec; 119(3):421-9. PubMed ID: 2906084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phorbol esters affect pituitary growth hormone (GH) and prolactin release: the interaction with GH releasing factor, somatostatin and bromocriptine.
    Summers ST; Canonico PL; MacLeod RM; Rogol AD; Cronin MJ
    Eur J Pharmacol; 1985 May; 111(3):371-6. PubMed ID: 2862049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Timing of exposure to somatostatin relative to growth hormone-releasing factor dictates the rat anterior pituitary cell growth hormone response.
    Richardson SB; Twente S
    J Endocrinol; 1993 Sep; 138(3):369-77. PubMed ID: 7903977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of GH-releasing peptide-6 (GHRP-6) and GHRP-2 on intracellular adenosine 3',5'-monophosphate (cAMP) levels and GH secretion in ovine and rat somatotrophs.
    Wu D; Chen C; Zhang J; Bowers CY; Clarke IJ
    J Endocrinol; 1996 Feb; 148(2):197-205. PubMed ID: 8699133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the involvement of calcium and calmodulin in the action of growth-hormone-releasing factor.
    Merritt JE; Dobson PR; Wojcikiewicz RJ; Baird JG; Brown BL
    Biosci Rep; 1984 Dec; 4(12):995-1000. PubMed ID: 6442170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative effects of thyroxine and/or retinoic acid treatment in vivo on growth hormone synthesis and release by pituitaries from thyroidectomized rats.
    Mulloy AL; Smith TJ; Stachura ME
    Horm Metab Res; 1992 Oct; 24(10):466-70. PubMed ID: 1464411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cycloheximide blocks insulin-like growth factor I but not somatostatin inhibition of growth hormone secretion.
    Sheppard MS; Bala RM
    Can J Physiol Pharmacol; 1987 Apr; 65(4):515-9. PubMed ID: 2886202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracellular pH and growth hormone-releasing factor-stimulated adenosine 3'5'-monophosphate, intracellular calcium and growth hormone release from rat anterior pituitary cells.
    Puttagunta AL; Chik CL; Girard M; O'Brien L; Ho AK
    J Endocrinol; 1992 Nov; 135(2):343-52. PubMed ID: 1335472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Desensitization to growth hormone-releasing factor (GRF) is associated with down-regulation of GRF-binding sites.
    Bilezikjian LM; Seifert H; Vale W
    Endocrinology; 1986 May; 118(5):2045-52. PubMed ID: 3009146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracellular calcium concentration and growth hormone secretion in individual somatotropes: effects of growth hormone-releasing factor and somatostatin.
    Holl RW; Thorner MO; Leong DA
    Endocrinology; 1988 Jun; 122(6):2927-32. PubMed ID: 2453353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modification of basal and GRF-stimulated cyclic AMP levels and growth hormone release by phospholipid metabolic enzyme inhibitors.
    Cronin MJ; MacLeod RM; Canonico PL
    Neuroendocrinology; 1985 Apr; 40(4):332-8. PubMed ID: 2986027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.